IPP Bureau
Safic-Alcan expands in India with majority stake in SA Ingredients
By IPP Bureau - May 07, 2026
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics
By IPP Bureau - May 07, 2026
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
By IPP Bureau - May 07, 2026
Approval strengthens the company’s growing international anti-infective portfolio
Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness
By IPP Bureau - May 07, 2026
The 40-second film brings children to the forefront of the narrative
GIMS Greater Noida expands paediatric orthopaedic care under Healthium's CSR initiative
By IPP Bureau - May 07, 2026
Supported by Plan International, the partnership will help treat over 1,000 children annually
Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion
By IPP Bureau - May 07, 2026
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
CARE Hospitals performs rare organ-preserving pancreatic surgery
By IPP Bureau - May 07, 2026
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
Experts call for easing access to 2mg and 4mg nicotine replacement therapies
By IPP Bureau - May 07, 2026
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
Free HLA typing for children with thalassaemia launched in India
By IPP Bureau - May 07, 2026
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
China poised to launch world’s first CAR-T therapy for gastric cancer
By IPP Bureau - May 07, 2026
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
Neurobion introduces nerve pain relief cream
By IPP Bureau - May 07, 2026
The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil
GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD
By IPP Bureau - May 07, 2026
This is an exciting and meaningful milestone for GRIN Therapeutics
Merck completes $5.8 billion acquisition of Terns Pharma
By IPP Bureau - May 07, 2026
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum
By IPP Bureau - May 07, 2026
The standout story remains Wegovy, particularly its new oral formulation
